Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

1.2K
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
1.2K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

597
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
597
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

364
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
364

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in the management of chest wall injuries - Influence of new technical options.

Injury·2026
Same author

Assessing the efficacy, safety and utility of fully closed-loop insulin delivery compared to standard insulin therapy with a continuous glucose monitor in adults with type 2 diabetes (COYOTE study): a randomised parallel study protocol.

BMJ open·2026
Same author

Alteration history of aluminum-rich rocks at Jezero crater, Mars.

Communications earth & environment·2025
Same author

Redox-driven mineral and organic associations in Jezero Crater, Mars.

Nature·2025
Same author

[The NIPPLE trial-On the secure placement of chest drains or why men and women may sometimes be really equal : German Congress for Orthopedics and Trauma Surgery (DKOU) Science Slam 2024].

Unfallchirurgie (Heidelberg, Germany)·2025
Same author

[Cancellous bone harvesting from the distal radius for reconstruction of bone defects in the hand].

Operative Orthopadie und Traumatologie·2024

Related Experiment Video

Updated: Apr 27, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K

A toolbox to improve algorithms for insulin-dosing decision support.

K Donsa1, P Beck1, J Plank2

  • 1HEALTH - Institute for Biomedicine and Health Sciences, JOANNEUM RESEARCH Forschungsgesellschaft mbH , Graz, Austria.

Applied Clinical Informatics
|July 16, 2014
PubMed
Summary

A new toolbox improves clinical decision-support algorithms for diabetes management, enabling personalized insulin dosing. This system aids healthcare professionals in optimizing patient care through data-driven insights.

Keywords:
algorithmsclinical decision support systemscomputer simulationdiabetes mellitus type 2workflow

More Related Videos

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

19.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.7K
Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
05:52

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster

Published on: June 30, 2011

19.3K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.9K

Area of Science:

  • Medical Informatics
  • Clinical Decision Support Systems
  • Diabetes Management

Background:

  • Clinical guidelines recommend standardized insulin order sets for inpatient diabetes management using basal-bolus insulin therapy.
  • The GlucoTab system, an algorithm-based tool, supports healthcare personnel with workflow and insulin dose suggestions.

Purpose of the Study:

  • To develop a versatile toolbox aimed at enhancing clinical decision-support algorithms.
  • The toolbox facilitates the improvement of diabetes treatment algorithms.

Main Methods:

  • A three-component toolbox was developed: data preparation from heterogeneous sources, simulation of treatment workflows using real clinical trial data, and analysis of algorithm performance.
  • Algorithm performance was evaluated using data from 166 patients across three clinical trials.

Main Results:

  • The toolbox facilitated significant improvements in existing algorithms.
  • It also identified potential for developing individualized algorithms tailored to specific patient subgroups.

Conclusions:

  • The developed toolbox represents a significant advancement in refining clinical decision-support tools.
  • This work is a foundational step towards personalized algorithm modifications for distinct patient subgroups in diabetes care.